SLC2A1 is a gene encoding a protein known as solute carrier family 2, member 1, also called GLUT1. This protein allows the transport of glucose into and out of neurons, thereby modulating the availability of this energy source. The effects of specific mutations in SLC2A1 can be ascertained by introducing a replica of the gene containing a particular mutation into cells and then assessing the behavior of those cells.

We are pleased to offer our mutation characterization and drug screening services for eligible pathogenic mutations within SLC2A1 at the current rate of $50,000 and an anticipated timeline of six months. Please contact us with interests and inquiries.